GSK-3beta inhibition: at the crossroad between Akt and mTOR constitutive activation to enhance cyclin D1 protein stability in mantle cell lymphoma (Q39943592)
scientific article published on 5 September 2008
Language:
Current Data About GSK-3beta inhibition: at the crossroad between Akt and mTOR constitutive activation to enhance cyclin D1 protein stability in mantle cell lymphoma
(P31) (Q13442814)
(P248)
(P698) 18769147
(P813) Friday, September 15, 2017

(P50) (Q37378489)
(P1545) 2
(P248)
(P698) 18769147
(P813) Friday, September 15, 2017

(P304) 2813-2816
(P248)
(P698) 18769147
(P813) Friday, September 15, 2017

(P433) 18
(P248)
(P698) 18769147
(P813) Friday, September 15, 2017

(P478) 7
(P248)
(P698) 18769147
(P813) Friday, September 15, 2017

(P577) Friday, September 5, 2008
(P248)
(P698) 18769147
(P813) Friday, September 15, 2017

(P1104) 4
(P887)

(P1433) (Q1254166)
(P248)
(P698) 18769147
(P813) Friday, September 15, 2017

(P1476) "GSK-3beta inhibition: at the crossroad between Akt and mTOR constitutive activation to enhance cyclin D1 protein stability in mantle cell lymphoma" (language: en)
(P248)
(P698) 18769147
(P813) Friday, September 15, 2017

(P2093) Jessica Dal Col
(P1545) 1
(P248)
(P698) 18769147
(P813) Friday, September 15, 2017

other details
description scientific article published on 5 September 2008

External Links
(P356) 10.4161/CC.7.18.6733
(P698) 18769147
(P5875) 23233889